6
Views
6
CrossRef citations to date
0
Altmetric
Original Article

The Immunogenetic Basis of Autoimmunity

&
Pages 293-306 | Received 09 Dec 1988, Accepted 26 Sep 1989, Published online: 07 Jul 2009

References

  • Diabetes Epidemiology Research International. Preventing insulin dependent diabetes mellitus: the environmental challenge. Br Med J 1987; 295: 479–481
  • Saiki R K, Bugawan T L, Horn Q T, Mullis K B, Erlick H A. Analysis of enzymatically amplified beta-globin and HLA-DQ-alpha DNA with allele-specific oligonucleotide probes. Nature 1986; 324: 163–166
  • Brewerton D A, Caffrey M, Hart F D, James D CO, Nicholls A, Sturrock R D. Anakylosing spondylitis and HLA 27. Lancet 1973; i: 904–907
  • Svejgaard A, Platz P, Ryder L P. HLA and disease 1982— a survey. Immunol Rev 1983; 70: 193–218
  • Todd J A, Bell J I, McDevitt H O. HLA-DQ-beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987; 329: 599–604
  • Singal D P, D'Souza M, Reid B, Bensen W G, Kassam Y B, Adachi J D. HLA-DQ beta-chain polymorphism in HLA-DR4 haplotypes associated with rheumatoid arthritis. Lancet 1987; II: 1118–1120
  • Sinha A A, Brautbar C, Szafer F, Friedmann A, Tzfoni E, Todd J A, Steinman L, McDevitt H O. A newly characterised HLA DQ-beta allele associated with pemphigus vulgaris. Science 1988; 239: 1026–1029
  • Bodmer J, Bodmer W. Histocompatibility. Immunol Today 1984 1984; 5: 251–254
  • Kantor F S, Ojeda A, Benacerraf B. Studies on artifical antigens. I. Antigenicity of DNP-polylysine and DNP copolymer of lysine and glutamic acid in guinea pigs. J Exp Med 1963; 117: 55–69
  • McDevitt H O, Sela M. Genetic control of the antibody response. 1. Demonstration of determinant-specific differences in response to synthetic polypeptide antigens in two strains of inbred mice. J Exp Med 1965; 122: 517–531
  • Ir genes: Forum d'immunologie. Ann lmmunol (Inst Pasteur) 1984; 135c: 379–423, Theze J. (ed)
  • Babbit B P, Allen P M, Matsueda G, Haber E, Unanue E R. Binding of immunogenic peptides to la histocompatibility molecules. Nature 1985; 317: 359–361
  • Buus S, Sette A, Colon A, Miles C, Grey H M. The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides. Science 1987; 235: 1353–1358
  • Lock C B, So A KL, Welsh K I, Parkes J K, Trowsdale J. MHC class II sequences of an HLA-DR2. narcolepic Immunogenetics 1988; 27: 449–455
  • Ebringer A, Deacon N J, Young C R. Codominant inheritance in immunogenetic (Ir-gene) systems. J Immunogenetics 1976; 3: 401–409
  • Glimcher L H, Shevach E M. Production of autoreactive I region-restricted T cell hybridomas. J Exp Med 1982; 156: 640–645
  • Oliveira D BG, Mitchison N A. Immune suppression genes. Clin Exp lmmunol 1989; 75: 167–177
  • Sadegh-Nasseri S, Dessi V, Sercarz E E. Selective reversal of H-2-linked genetic unresponsiveness to lysozymes. II. Alteration in the T helper/T suppressor balance, owing to gene(s) linked to Ir-2, leads to responsiveness in Balb.B. Eur J Immunol 1986; 16: 486–492
  • Oliveira D BG, Nardi N B. Immune suppression genes control the anti-F antigen response in F1 hybrids and recombinant inbred sets of mice. Immunogenetics 1987; 26: 359–365
  • Yasunami R, Bach J-F. Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur J Immunol 1988; 18: 481–484
  • Hattori M, Buse J B, Jackson R A, Glimcher L, Dorf M E, Minami M, Makino S, Moriwaki K, Kuzuya H, Imura H, Strauss W M, Seidman J G, Eisenbarth G S. The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. Science 1986; 231: 733–735
  • Nishimoto H, Kikutani H, Yamamura K, Kishimoto T. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice. Nature 1987; 328: 432–434
  • Hohlfeld R, Toyka K V, Tzartos S J, Carson W, Conti-Tronconi B M. Human T-helper lymphocytes in myasthenia gravis recognize the nicotinic receptor alpha subunit. Proc Natl Acad Sci USA 1987; 84: 5379–5383
  • Lake P, Mitchison N A. Associative control of the immune response to cell surface antigens. Immunol Commun 1976; 5: 795–805
  • Rothbard J, Townsend A, Edwards M, Taylor W. Pattern recognition among T cell epitopes. Hamarol Blurtransfus 1987; 31: 324–331
  • Margalit H, Spouge J L, Cornette J L, Cease K B, DeLisis C, Berzofsky J A. Prediction of im-munodominant helper T cell antigenic sites from the primary sequence. J Immunol 1987; 138: 2213–2229
  • Shastri N, Miller A, Sercarz E E. Aminoacid residues distinct from the determinant region can profoundly affect activation of T cell clones by related antigens. J Immunol 1986; 136: 371–376
  • Hohlfeld R, Toyka K V, Heininger K, Grosse-Wilde H, Kalies I. Autoimmune human T lymphocytes specific for acetylcholine receptor. Nature 1984; 310: 244–246
  • Londei M, Bottazzo G F, Feldmann M. Human T-cell clones from autoimmune thyroid glands: specific recognition of autologous thyroid cells. Science 1985; 228: 85–89
  • De Berardinis P, Londei M, James R FL, Lake S P, Wise P H, Feldmann M. Do CD4-positive cytotoxic T cells damage islet β cells in type I diabetes. Lancet 1988; ii: 823–824
  • MacKay I R. Natural autoantibodies to the fore — forbidden clones to the rear. Immunol Today 1983; 4: 340–342
  • Vakil M, Kearney J F. Functional characterisation of monoclonal auto-anti-idiotype antibodies isolated from the early B cell repertoire of BALB/c mice. Eur J Immunol 1986; 16: 1151–1158
  • Mitchison N A. Four intermediate concentration proteins and their message for self-tolerance, au-toimmunity, and suppressor epitopes. Clinical Immunology Newsleiter 1985; 6: 12–14
  • Kappler J W, Roehm N, Marrack P. T cell tolerance by clonal elimination in the thymus. Cell 1987; 49: 273–280
  • Kappler J W, Staerz U, White J, Marrack P C. Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex. Nature 1988; 322: 35–40
  • MacDonald H R, Schneider R, Lees R K, Howe R C, Acha-Orba H, Festenstein H, Zinkernagel R M, Hengartner H. T-cell receptor V beta use predicts reactivity and tolerance to MIS'-encoded antigens. Nature 1988; 332: 40–45
  • Kisielow P, Teh H S, Blüthmann H, von Boehmer H. Positive selection of antigen-specific T cells in thymus by restricting MHC molecules. Nature 1988; 335: 730–733
  • Demaine A G, Vaughan R W, Taube D H, Welsh K I. Association of membranous nephropathy with T-cell receptor constant beta chain and immunoglobulin heavy chain switch region polymorphisms. Immunogenetics 1988; 27: 19–23
  • Weetman A P, So A K, Roe C, Walport M J, Foroni L. T cell receptor a chain V region polymorphism linked to primary autoimmune hypothyroidism but not Graves' disease. Hum Immunol 1987; 20: 167–173
  • Hoover M L, Angelini G, Ball E, Ferrara G B, Marks J, Raskin P, Rosenstock J, Stastny P, Tosi R, Capra J D. Insulin dependant diabetes mellitus is associated with polymorphic forms of the T cell receptor beta chain gene. Clin Research 1986; 34: 725A
  • Demain A G, Welsh K I, Hawe D G, Williams D G, Farid N R. The T cell receptor beta chain genes are associated with Graves' disease. Clin Science 1987; 72(suppl 16)62P
  • Millward B A, Welsh K I, Leslie R DG, Pyke D A, Demaine A G. T cell receptor beta chain polymorphisms are associated with insulin-dependent diabetes. Clin Exp Immunol 1987; 70: 152–157
  • Weetman A P, So A K, Warner C A, Foroni L, Fells P, Shine B. Immunogenetics of Graves' ophthal-mopathy. Clin Endocrinol 1988; 28: 619–628
  • Rees A J, Peters D K, Amos N, Welsh K I, Batchelor J R. The influence of HLA-linked genes on the seventy of anti-GBM antibody-mediated nephritis. Kidney Int 1984; 26: 444–450
  • Morimoto C, Letvin N L, Distaso J A, Brown H M, Schlossman S F. The cellular basis for the induction of antigen-specific T8 suppressor cells. Eur J Immunol 1986; 16: 198–204
  • Damle N K, Childs A L, Doyle L V. lmmunoregulatory T lymphocytes in man. Soluble antigen-specific suppressor-inducer T lymphocytes are derived from the CD4+ CD45R- p80+ subpopulation. J Immunol 1987; 139: 1501–1508
  • Morimoto C, Hafler D A, Weiner H L, Letvin N L, Hagan M, Daley J, Schlossman S F. Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody. N Eng J Med 1987; 316: 67–72
  • Akbar A N, Terry L, Timms A, Beverley P CL, Janossy G. Loss of CD45R and gain of UCHLI reactivity is a feature of primed T cells. J Immunol 1988; 140: 2171–2178
  • Vento S, O'Brien C J, McFarlane I G, Williams R, Eddleston A LWF. T-cell inducers of suppressor lymphocytes control liver-directed autoimmunity. Lancet 1987; i: 886–888
  • O'Brien C J, Vento S, Donaldson P T, McSorley C G, McFarlane I G, Williams R, Edddleston A LWF. Cell-mediated immunity and suppressor-T-cell defects to liver-derived antigens in families of patients with autoimmune chronic active hepatitis. Lancet 1986; i: 350–353
  • Nouri-Aria K T, Donaldson P T, Hegarty J E, Eddleston A LWF, Williams R. HLA A1-B8-DR3 and suppressor cell function in first degree relatives of patients with autoimmune chronic active hepatitis. J Hepatol 1985; 1: 235–241
  • Volpé R. Hypothesis: the immunoregulatory disturbance in autoimmune thyroid disease. Autoimmunity 1988; 55–72
  • Ludgate M E, Ratanachaiyavong S, Weetman A P, Hall R, McGregor A M. Failure to demonstrate cell-mediated immune responses to thyroid antigens in Graves' disease using in vitro assays of lymphokine-mediated migration inhibition. J Clin Endocrinol Merab 1985; 60: 98–102
  • Topliss D, How J, Lewis M, Row V, Volpé R. Evidence for cell-mediated immunity and specific suppressor T lymphocyte dysfunction in Graves' disease and diabetes mellitus. J Clin Endrocrinol Metab 1983; 57: 700–705
  • Corazza G R, Sachielli P, Londei M, Frisoni M, Gasparini G. Gluten specific suppressor T cell function in coeliac disease. Gut 1986; 27: 392–398
  • Miller K B, Schwartz R S. Familial abnormalities of suppressor-cell function in systemic lupus erythe-matosus. N Eng J Med 1979; 301: 803–809
  • Miller K B, Sepersky R A, Brown K M, Goldberg M J, Kaplan M M. Genetic abnormalities of im-munoregulation in primary biliary cirrhosis. Am J Med 1983; 75: 75–80
  • Rees A J, Demaine A G, Welsh K I. The association between immunoglobulin allotypes with auto-antibodies to glomerular basement membrane and their titre. Hum Immunol 1984; 10: 213–221
  • Migone N, Feder H, Cann H, Van West B, Hwang H, Takahashi N, Honjo T, Piazza A, Cavalli-Sfor-Za L L. Multiple DNA fragment polymorphisms associated with immunoglobulin μ chain swich-like regions in man. Proc Natl Acad Sci USA 1983; 80: 467–471
  • Shlomchik M J, Nemazee D A, Sato V L, van Snick J, Carson D A, Weigert M G. Variable region sequences of murine IgM anti-IgG monoclonal autoantibodies (rheumatoid factors). A structural explanation for the high frequency of IgM anti-IgG B cells. J Exp Med 1986; 164: 407–427
  • Neilson E G, McCafferty E, Mann R, Michaud L, Clayman M. Tubular antigen-derivatised cells induce a disease-protective, antigen-specific, and idiotype-specific suppressor T cell network restricted by I-J and Igh-V in mice with experimental interstitial nephritis. J Exp Med 1985; 162: 215–230
  • Hayglass K T, Benacerraf B, Sy M-S. T cell development in B cell-deficient mice. V. Stopping anti-μ treatment results in Igh-restricted expansion of the T suppressor cell repertoire concomitant with the development of normal immunoglobulin levels. J Exp Med 1986; 164: 36–49
  • Bluestein H G, Green L, Maurer P H, Benacerraf B. Specific immune response genes of the guinea pig. V. Influence of the GA and GT immune response genes on the specificity of cellular and humoral immune responses to a terpolymer of L-glutamic acid, L-alanine, and L-tyrosine. J Exp Med 1972; 135: 98–109
  • Berzofsky J A, Schechter A N, Shearer G M, Sachs D H. Genetic control of the immune response to Staphylococcal nuclease. IV. H-2-linked control of the relative proportions of antibodies produced to different determinants of native nuclease. J Exp Med 1977; 145: 123–135
  • Berzofsky J A. T-B reciprocity. An la-restricted epitope-specific circuit regulating T cell-B cell interaction and antibody specificity. Surv Immunol Res 1983; 2: 223–229
  • Nossal G JV. Cellular mechanisms of immunologic tolerance. Ann Rev Immunol 1983; 1: 33–62
  • Goodnow C C, Crosbie J, Adelstein S, Lavoie T B, Smith-Gill S J, Pritchard-Briscoe H, Wotherspoon J S, Loblay R H, Raphael K, Trent R J, Basten A. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 1988; 334: 676–682
  • Pressey A, Pusey C D, Dash A, Peters D K, Lockwood C M. Production of a monoclonal antibody to autoantigenic components of human glomerular basement membrane. Clin Exp Immunol 1983; 54: 178–184
  • Clayman M D, Sun M J, Michaud L, Brill-Dashoff J, Riblet R, Neilson E G. Clonotypic heterogeneity in experimental interstitial nephritis. Restricted specificity of the anti-tubular basement membrane B cell repertoire is associated with a disease-modifying crossreactive idiotype. J Exp Med 1988; 167: 1296–1312
  • Doble N D, Banga J P, Pope R, Lalor E, Kilduff P, McGregor A M. Autoantibodies to the thyroid microsomal/thyroid peroxidase antigen are polyclonal and directed to several distinct antigenic sites. Immunology 1988; 64: 23–29
  • Frank M M. Complement in the pathophysiology of human disease. N Eng J Med 1987; 316: 1525–1530
  • Fielder A HL, Walport M J, Batchelor J R, Rynes R I, Black C M, Dodi I A, Hughes G RV. Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. Br Med J 1983; 286: 425–428
  • Lachmann P J. Complement — friend or foe. Br J Rheumatol 1987; 26: 409–415
  • Schena P F, Pastore A, Sinico R A, Montinaro V, Fornasieri A. Polymeric IgA and IgA rheumatoid factor decrease the capacity of serum to solubilise circulating immune complexes in patients with primary IgA nephropathy. J Immunol 1988; 141: 125–130
  • Biozzi G, Mouton D, Heumann A M, Bouthillier Y, Stiffel C, Mevel J C. Genetic analysis of antibody responsiveness to sheep erythrocytes in crosses between lines of mice selected for high and low antibody synthesis. Immunology 1979; 36: 427–438
  • Wick G. Concept of a multigenic basis for the pathogenesis of spontaneous autoimmune thyroiditis. Acta Endocrinol 1987; 115(suppl 2)816–369
  • Sasazuki T, Nishimura Y, Muto M, Ohta N. HLA-linked genes controlling immune response and disease susceptibility. Immunol Rev 1983; 70: 51–75
  • Hirayama K, Matsushita S, Kikuchi I, Iuchi M, Ohta N, Sasazuki T. HLA-DQ is epistatic to HLA-DR in controlling the immune response to schistosomal antigen in humans. Nature 1987; 327: 426–430
  • Padula S, Pollard M K, Luigenheld E G, Clark R B. Maintenance of antigen specificity by human interleukin-2-dependent T cell lines. Use of antigen-presenting cells and OKT3 antibody in the absence of antigen. J Clin Invest 1985; 74: 788–797
  • Abou-Zeid C, Filley E, Steele J, Rook G AW. A simple new method for using antigen separated by polyacrylamide gel electrophoresis to stimulate lymphocytes in vitro after converting bands cut from western blots into antigen-bearing particles. J Immunol Methods 1987; 98: 5–10
  • Griffiths J, Mitchison N A, Oliveira D BG, Salgame P. New developments in epitope analysis. Progress in Vaccinology I, G. P. Talwar. Springer-Verlag, New York 1988; 359–367
  • Lamb J R, Rees A DM, Bal V, Ikeda H, Wilkinson D, De Vries R RP, Rothbard J B. Prediction and identification of an HLA-DR-restricted T cell determinant in the 19-kDa protein of Mycobacterium tuberculosis. Eur J Immunol 1988; 18: 973–976
  • Gershwin M E, MacKay I R, Sturgess A, Coppel R L. Identification and specificity of a cDNA encoding the 70 kD mitochondria1 antigen recognised in primary biliary cirrhosis. J Immunol 1987; 138: 3525–3531
  • Gascoigne N RJ, Crispe I N. Suppression of the cytotoxic T cell response to minor alloantigens in vivo. Linked recognition by suppressor T cells. Eur J Immunol 1984; 14: 210–215
  • Hutchison I V, Barber W H, Morris P J. Specific suppression of allograft rejection by trinitrophenol (TNP)-induced suppressor cells in recipients treated with TNP-haptenated donor alloantigens. J Exp Med 1985; 162: 1409–1420

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.